NCT06422338View on ClinicalTrials.gov

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

NARecruitingINTERVENTIONAL

Enrollment

5,212

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

March 1, 2027

Conditions

Infectious DiseaseFebrile IllnessChild, Only

Interventions

OTHER

IMCI-enhanced by suPAR levels (SoC + suPAR POC)

IMCI-guidelines (standard of care) + Point-Of-Care (POC) based on suPAR quantification

Trial Locations (1)

Unknown

RECRUITING

Mopeia Sede Health Centre, Mopeia

All Listed Sponsors

lead

Barcelona Institute for Global Health

OTHER

NCT06422338 - A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients) | Biotech Hunter | Biotech Hunter